+ All Categories
Home > Healthcare > 3 Horrendous Healthcare Stocks This Week 3-28-14

3 Horrendous Healthcare Stocks This Week 3-28-14

Date post: 22-Aug-2014
Category:
Upload: the-motley-fool
View: 11,466 times
Download: 10 times
Share this document with a friend
Description:
This week's most horrendous healthcare stocks.
10
3 Horrendous Health-Care Stocks This Week
Transcript
Page 1: 3 Horrendous Healthcare Stocks This Week   3-28-14

3 Horrendous Health-Care Stocks This Week

Page 2: 3 Horrendous Healthcare Stocks This Week   3-28-14

Has the so-called biotech bubble burst? Two of this week’s most horrendous health-care stocks bolster the theory, while the third stock could simply be experiencing the effects of market gravity.

Source: Wikimedia Commons

Page 3: 3 Horrendous Healthcare Stocks This Week   3-28-14

The biotech’s shares plunged more than 46% for the week.

Exelixis (Nasdaq: EXEL)

Source: Yahoo! Finance

Page 4: 3 Horrendous Healthcare Stocks This Week   3-28-14

• It announced on Tuesday the completion of an interim analysis of Cometriq and that the phase 3 prostate cancer trial would continue to final analysis.

• Many observers expected the study would be stopped early, as Johnson & Johnson’s Zytiga and Medivation’s Xtandi were.

• Exelexis expects top-line data from the phase 3 study later this year.

Why Exelixis got clobbered

Page 5: 3 Horrendous Healthcare Stocks This Week   3-28-14

Shares of the cloud-based health-care technology company dropped 27% this week.

Castlight Health (NYSE: CSLT)

Source: Yahoo! Finance

Page 6: 3 Horrendous Healthcare Stocks This Week   3-28-14

• Castlight’s IPO was last week, with the stock vaulting nearly 150% on its first day of trading.

• With only $13 million in revenue, Castlight’s market cap hit $3 billion.

• The backlash is apparently now under way, with plenty of critics.

• Yahoo! Finance called Castlight the “most overpriced IPO of the century.”

Why Castlight’s stock careened

Page 7: 3 Horrendous Healthcare Stocks This Week   3-28-14

The stock of the biopharmaceutical company fell 24% this week.

Galena Biopharma (Nasdaq: GALE)

Source: Yahoo! Finance

Page 8: 3 Horrendous Healthcare Stocks This Week   3-28-14

• This week’s decline appears to be a continuation from last week’s announcement of an SEC investigation.

• The investigation stems from alleged questionable stock-promotions efforts by The DreamTeam Group, particularly involving the posting of positive articles about Galena.

• Several online financial sites, including The Motley Fool, pulled articles related to the controversy over the past few months.

Why Galena shares dropped

Page 9: 3 Horrendous Healthcare Stocks This Week   3-28-14

• While Castlight’s business model is compelling, the stock really is overpriced right now.

• Galena could certainly come back with good news from cancer immunotherapy Neuvax.

• Exelixis gets the nod as the most likely to rebound.

• Continuation of the Cometriq study was disappointing, but the market overreacted, in my view.

Best shot at bouncing back?

?

Page 10: 3 Horrendous Healthcare Stocks This Week   3-28-14

Find out which stock The Motley Fool’s chief investment officer selected as the top pick for

2014 in our free report!


Recommended